Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
Investigating the Efficacy of Subcutaneous Testosterone Compared to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
Sponsor: Oregon Health and Science University
A EARLY_PHASE1 clinical study on Health Services for Transgender Persons and Transgender Persons, this trial is completed. The trial is conducted by Oregon Health and Science University and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
May 2024 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Unknown Status → Completed
-
Oct 2021 — May 2024 [monthly]
Unknown Status EARLY_PHASE1
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 2 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Sep 2019 [monthly]
Recruiting EARLY_PHASE1
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .